300149 睿智医药
已收盘 05-15 15:00:00
资讯
新帖
简况
睿智医药（300149）披露关于为全资子公司提供担保的进展公告，5月15日股价下跌0.94%
证券之星 · 05-15 17:29
睿智医药（300149）披露关于为全资子公司提供担保的进展公告，5月15日股价下跌0.94%
睿智医药（300149）披露2025年度网上业绩说明会安排，5月08日股价上涨0.7%
证券之星 · 05-08
睿智医药（300149）披露2025年度网上业绩说明会安排，5月08日股价上涨0.7%
股市必读：睿智医药（300149）4月30日披露最新机构调研信息
证券之星 · 05-06
股市必读：睿智医药（300149）4月30日披露最新机构调研信息
每周股票复盘：睿智医药（300149）股东户数增23.57%，一季报净利降373.36%
证券之星 · 05-03
每周股票复盘：睿智医药（300149）股东户数增23.57%，一季报净利降373.36%
睿智医药(300149)4月10日股东户数4.57万户，较上期增加23.57%
证券之星 · 04-29
睿智医药(300149)4月10日股东户数4.57万户，较上期增加23.57%
图解睿智医药一季报：第一季度单季净利润同比下降373.36%
证券之星 · 04-29
图解睿智医药一季报：第一季度单季净利润同比下降373.36%
睿智医药：公司定增项目目前仍在深交所审核过程中
证券之星 · 04-23
睿智医药：公司定增项目目前仍在深交所审核过程中
睿智医药：未聚焦单一锂系试剂连续流技术
证券之星 · 04-21
睿智医药：未聚焦单一锂系试剂连续流技术
睿智医药：参加AACR 2026年会并展示肿瘤学研究成果
证券之星 · 04-21
睿智医药：参加AACR 2026年会并展示肿瘤学研究成果
股市必读：睿智医药（300149）4月20日董秘有最新回复
证券之星 · 04-21
股市必读：睿智医药（300149）4月20日董秘有最新回复
睿智医药：截止到2026年4月10日，公司股东人数是45,729
证券之星 · 04-15
睿智医药：截止到2026年4月10日，公司股东人数是45,729
睿智医药：截止到2026年3月31日，公司的股东人数为37,007
证券之星 · 04-02
睿智医药：截止到2026年3月31日，公司的股东人数为37,007
睿智医药：截止到2026年3月20日，公司股东人数为35,128
证券之星 · 03-25
睿智医药：截止到2026年3月20日，公司股东人数为35,128
股市必读：睿智医药（300149）3月20日披露最新机构调研信息
证券之星 · 03-23
股市必读：睿智医药（300149）3月20日披露最新机构调研信息
睿智医药（300149）披露2026年第一次临时股东会决议公告，3月20日股价下跌3.02%
证券之星 · 03-20
睿智医药（300149）披露2026年第一次临时股东会决议公告，3月20日股价下跌3.02%
股市必读：睿智医药（300149）3月16日披露最新机构调研信息
证券之星 · 03-17
股市必读：睿智医药（300149）3月16日披露最新机构调研信息
睿智医药：东吴证券投资者于3月13日调研我司
证券之星 · 03-16
睿智医药：东吴证券投资者于3月13日调研我司
睿智医药：公司于2024年底启动两个ADC整包服务项目
证券之星 · 03-12
睿智医药：公司于2024年底启动两个ADC整包服务项目
股市必读：睿智医药(300149)股东户数3.64万户，较上期增加0.01%
中金财经 · 03-05
股市必读：睿智医药(300149)股东户数3.64万户，较上期增加0.01%
睿智医药：截至2026年2月27日，公司股东人数为36,371人
证券之星 · 03-04
睿智医药：截至2026年2月27日，公司股东人数为36,371人
暂无数据
公司概况
公司名称：
睿智医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2010-12-22
主营业务：
睿智医药科技股份有限公司的主营业务是提供涵盖化学药研发以及生物药从早期发现到开发与规模化生产阶段的一体化服务。公司的主要产品是化学业务、药效药动业务、大分子业务。
发行价格：
28.00
{"stockData":{"symbol":"300149","market":"SZ","secType":"STK","nameCN":"睿智医药","latestPrice":9.44,"timestamp":1778828610000,"preClose":9.53,"halted":0,"volume":11665000,"delay":0,"changeRate":-0.0094,"floatShares":475000000,"shares":498000000,"eps":-0.0229,"marketStatus":"已收盘","change":-0.09,"latestTime":"05-15 15:00:00","open":9.5,"high":9.74,"low":9.36,"amount":111000000,"amplitude":0.0399,"askPrice":9.44,"askSize":30,"bidPrice":9.43,"bidSize":219,"shortable":0,"etf":0,"ttmEps":-0.0229,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779067800000},"marketStatusCode":5,"adr":0,"adjPreClose":9.53,"symbolType":"stock","openAndCloseTimeList":[[1778808600000,1778815800000],[1778821200000,1778828400000]],"highLimit":10.48,"lowLimit":8.58,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":497963992,"isCdr":false,"pbRate":3.7,"roa":"--","roe":"--","epsLYR":0.03,"committee":-0.509155,"marketValue":4701000000,"turnoverRate":0.0246,"status":1,"floatMarketCap":4480000000},"requestUrl":"/m/hq/s/300149/tweets","defaultTab":"tweets","newsList":[{"id":"2635037707","title":"睿智医药（300149）披露关于为全资子公司提供担保的进展公告，5月15日股价下跌0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635037707","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635037707?lang=zh_cn&edition=full","pubTime":"2026-05-15 17:29","pubTimestamp":1778837364,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，睿智医药报收于9.44元，较前一交易日下跌0.94%，最新总市值为47.01亿元。近日，睿智医药科技股份有限公司披露《关于担保进展的公告》。本次担保在公司已审批的担保额度范围内，无需另行提交董事会或股东会审议。截至公告日，公司及控股子公司担保额度总金额为90,324.82万元，实际担保余额为8,535.81万元，占公司2025年度经审计净资产的6.69%，无逾期担保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500031855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633343413","title":"睿智医药（300149）披露2025年度网上业绩说明会安排，5月08日股价上涨0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633343413","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633343413?lang=zh_cn&edition=full","pubTime":"2026-05-08 17:58","pubTimestamp":1778234283,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，睿智医药报收于10.05元，较前一交易日上涨0.7%，最新总市值为50.05亿元。近日，睿智医药科技股份有限公司发布《关于举行2025年度网上业绩说明会的公告》。公告显示，公司已于2026年4月29日披露《2025年年度报告》及其摘要，为进一步加强与投资者的沟通，将于2026年5月18日15:00-17:00通过深圳证券交易所‘互动易’平台举行2025年度网上业绩说明会，采用网络远程方式召开。投资者可提前登录‘互动易’平台提交问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800032422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633920005","title":"股市必读：睿智医药（300149）4月30日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2633920005","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633920005?lang=zh_cn&edition=full","pubTime":"2026-05-06 06:01","pubTimestamp":1778018508,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，睿智医药报收于9.99元，下跌0.1%，换手率2.56%，成交量12.16万手，成交额1.22亿元。当日关注点来自交易信息汇总：4月30日主力资金净流出243.24万元，散户资金净流入820.19万元，占总成交额6.74%。新模态业务订单中，XDC相关订单占比接近50%，其次为多肽与核酸类订单；2026年一季度小核酸业务订单呈增长趋势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600004155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0216","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632113670","title":"每周股票复盘：睿智医药（300149）股东户数增23.57%，一季报净利降373.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632113670","media":"证券之星","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632113670?lang=zh_cn&edition=full","pubTime":"2026-05-03 07:04","pubTimestamp":1777763057,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，睿智医药报收于9.99元，较上周的10.57元下跌5.49%。本周，睿智医药4月28日盘中最高价报10.88元。业绩披露要点：2026年一季度归母净利润-1815.65万元，同比下降373.36%。股本股东变化股东户数变动截至2026年4月10日，公司股东户数为4.57万户，较3月31日增加8722.0户，增幅为23.57%。户均持股数量由上期的1.35万股减少至1.09万股，户均持股市值为12.2万元。2026年一季度小核酸业务订单呈增长趋势。该预案尚需提交股东会审议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300001699.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300149","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631990115","title":"睿智医药(300149)4月10日股东户数4.57万户，较上期增加23.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631990115","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631990115?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:59","pubTimestamp":1777456774,"startTime":"0","endTime":"0","summary":"证券之星消息，近日睿智医药披露，截至2026年4月10日公司股东户数为4.57万户，较3月31日增加8722.0户，增幅为23.57%。在医疗服务行业个股中，睿智医药股东户数低于行业平均水平，截至4月10日，医疗服务行业平均股东户数为4.91万户。从股价来看，2026年3月31日至2026年4月10日，睿智医药区间涨幅为8.21%，在此期间股东户数增加8722.0户，增幅为23.57%。近3个月融资净流入3181.82万，融资余额增加；融券净流出3.37万，融券余额减少。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900056709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK0077","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631369435","title":"图解睿智医药一季报：第一季度单季净利润同比下降373.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631369435","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631369435?lang=zh_cn&edition=full","pubTime":"2026-04-29 04:30","pubTimestamp":1777408227,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药2026年一季报显示，一季度公司主营收入2.67亿元，同比上升2.08%；归母净利润-1815.65万元，同比下降373.36%；扣非净利润-1975.03万元，同比下降1157.2%；负债率35.71%，投资收益-7.15万元，财务费用790.78万元，毛利率22.15%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900009632.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629834175","title":"睿智医药：公司定增项目目前仍在深交所审核过程中","url":"https://stock-news.laohu8.com/highlight/detail?id=2629834175","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629834175?lang=zh_cn&edition=full","pubTime":"2026-04-23 20:51","pubTimestamp":1776948665,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药(300149)04月22日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司睿智的领导们减持进度如何了？是否减持满意了？另外拖了多半年的定增有消息了么？谢谢睿智医药回复：尊敬的投资者，您好！感谢对公司的关注。关于股东的减持情况请关注公司披露的相关公告。公司定增项目目前仍在深交所审核过程中，公司将持续推动相关工作，并严格按照法律法规要求及时披露信息。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300059075.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300149","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629908843","title":"睿智医药：未聚焦单一锂系试剂连续流技术","url":"https://stock-news.laohu8.com/highlight/detail?id=2629908843","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629908843?lang=zh_cn&edition=full","pubTime":"2026-04-21 15:04","pubTimestamp":1776755057,"startTime":"0","endTime":"0","summary":"您所提及的仲丁基锂相关工艺，在公司整体研发与服务体系中应用场景有限、使用量较小。公司并未聚焦于单一锂系试剂的连续流技术，而是重点布局应用场景更广泛的微流控平台技术，目前已在小核酸药物等领域持续推进技术布局，打造差异化服务能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100029315.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629088174","title":"睿智医药：参加AACR 2026年会并展示肿瘤学研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2629088174","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629088174?lang=zh_cn&edition=full","pubTime":"2026-04-21 15:04","pubTimestamp":1776755057,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药04月21日在投资者关系平台上答复投资者关心的问题。谢谢睿智医药回复：尊敬的投资者，您好！公司正在参加于4月17日至21日在美国圣地亚哥举行的AACR 2026年会，并设置展台，届时将进行1场口头报告及5项学术海报展示，内容涵盖公司肿瘤学研究相关成果。公司深耕CRO/CDMO领域二十余年。此次参展旨在展示公司在肿瘤药物研发领域的技术实力，并与全球生物医药创新企业开展合作交流。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100029312.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629720044","title":"股市必读：睿智医药（300149）4月20日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2629720044","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629720044?lang=zh_cn&edition=full","pubTime":"2026-04-21 01:44","pubTimestamp":1776707084,"startTime":"0","endTime":"0","summary":"截至2026年4月20日收盘，睿智医药报收于11.18元，上涨0.81%，换手率4.31%，成交量20.45万手，成交额2.27亿元。董秘最新回复投资者： 公司定增为何迟迟不获批?这样一直拖着 严重影响股价董秘： 尊敬的投资者，您好！公司定增项目目前仍在深交所审核过程中，公司将积极推动相关工作，并严格按照法律法规要求及时披露信息。当日关注点来自交易信息汇总：4月20日主力资金净流出135.35万元，游资资金净流入356.25万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042100004169.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0216","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627723404","title":"睿智医药：截止到2026年4月10日，公司股东人数是45,729","url":"https://stock-news.laohu8.com/highlight/detail?id=2627723404","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627723404?lang=zh_cn&edition=full","pubTime":"2026-04-15 16:18","pubTimestamp":1776241088,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药(300149)04月15日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截止到2026年4月10日公司股东人数是多少？谢谢！睿智医药回复：尊敬的投资者，您好！感谢对公司的关注。截止到2026年4月10日，公司股东人数是45,729。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041500028988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300149","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624527579","title":"睿智医药：截止到2026年3月31日，公司的股东人数为37,007","url":"https://stock-news.laohu8.com/highlight/detail?id=2624527579","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624527579?lang=zh_cn&edition=full","pubTime":"2026-04-02 15:48","pubTimestamp":1775116088,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药(300149)04月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2026年3月 31日公司的股东总数是多少？谢谢睿智医药回复：尊敬的投资者，您好！感谢对公司的关注。截止到2026年3月31日，公司的股东人数为37,007。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200022857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622388046","title":"睿智医药：截止到2026年3月20日，公司股东人数为35,128","url":"https://stock-news.laohu8.com/highlight/detail?id=2622388046","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622388046?lang=zh_cn&edition=full","pubTime":"2026-03-25 11:30","pubTimestamp":1774409449,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药(300149)03月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止3月20日公司股东人数是多少？睿智医药回复：尊敬的投资者，您好！感谢对公司的关注。截止到2026年3月20日，公司股东人数为35,128。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500019205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300149","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621746145","title":"股市必读：睿智医药（300149）3月20日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2621746145","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621746145?lang=zh_cn&edition=full","pubTime":"2026-03-23 03:17","pubTimestamp":1774207031,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，睿智医药报收于9.62元，下跌3.02%，换手率1.58%，成交量7.49万手，成交额7350.48万元。整包订单转化正稳步加速，预计相关订单确认将从2026年下半年起逐步落地，并在2027年实现稳步拓展。公司将持续关注进展，并按规定履行信息披露义务。其中，享百年健康科技出资335万元，持股67%；安欣投资出资165万元，持股33%。近日，该合资公司已完成工商登记，并取得广州市越秀区市场监督管理局颁发的营业执照。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300001307.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0077","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620578455","title":"睿智医药（300149）披露2026年第一次临时股东会决议公告，3月20日股价下跌3.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620578455","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620578455?lang=zh_cn&edition=full","pubTime":"2026-03-20 17:29","pubTimestamp":1773998982,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，睿智医药报收于9.62元，较前一交易日下跌3.02%，最新总市值为47.9亿元。该股当日开盘9.92元，最高10.09元，最低9.62元，成交额达7350.48万元，换手率为1.58%。睿智医药于近日披露《2026年第一次临时股东会决议公告》。公告显示，公司于2026年3月19日召开2026年第一次临时股东会，会议采用现场与网络投票结合方式，由董事会召集，董事长WOO SWEE LIAN主持。出席会议股东共242人，代表股份134,340,773股，占总股本26.9780%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000030522.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620931384","title":"股市必读：睿智医药（300149）3月16日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2620931384","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620931384?lang=zh_cn&edition=full","pubTime":"2026-03-17 02:12","pubTimestamp":1773684734,"startTime":"0","endTime":"0","summary":"截至2026年3月16日收盘，睿智医药报收于10.2元，上涨0.59%，换手率1.39%，成交量6.59万手，成交额6706.11万元。当日关注点来自交易信息汇总：3月16日主力资金净流入92.72万元，散户资金同步增持。来自机构调研要点：公司联合华东师范大学推出全球首创DC与核苷酸单体微流控合成系统，强化超限智造技术应用。2025年实施限制性股票激励计划，覆盖核心管理与技术骨干，绑定长期发展目标。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700001786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0216","300149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619456898","title":"睿智医药：东吴证券投资者于3月13日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2619456898","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619456898?lang=zh_cn&edition=full","pubTime":"2026-03-16 17:11","pubTimestamp":1773652318,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年3月16日睿智医药发布公告称东吴证券于2026年3月13日调研我司。在自动化实验室建设方面，公司与苏州镁伽科技达成深度战略合作，聚焦从概念验证到 PCC的关键研发阶段，共同打造睿智自动化实验室，实现高通量、信息化、一体化的研发能力升级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600023161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","300149","BK0276","BK0028","BK0216","BK0009","BK0012","BK0183","BK0077","601555"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618183060","title":"睿智医药：公司于2024年底启动两个ADC整包服务项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2618183060","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618183060?lang=zh_cn&edition=full","pubTime":"2026-03-12 15:06","pubTimestamp":1773299176,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药03月11日在投资者关系平台上答复投资者关心的问题。感觉公司2025年没有签署新的整包服务订单。公司于2024 年底启动两个 ADC 整包服务项目，整包服务能力已获得客户认可。在持续拓展整包服务业务机会的同时，公司自 2025 年下半年起积极探索通过投资产业基金开展前瞻性布局，围绕创新药产业链挖掘优质项目资源，既能助力产业基金筛选、验证与执行项目，也可为公司整包服务订单储备优质资源，夯实长期业务发展基础。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031200018978.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300149","BK0216","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617598848","title":"股市必读：睿智医药(300149)股东户数3.64万户，较上期增加0.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617598848","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617598848?lang=zh_cn&edition=full","pubTime":"2026-03-05 07:58","pubTimestamp":1772668712,"startTime":"0","endTime":"0","summary":"h2,h3,h4{padding: 10px 0;font-size: 16px;line-height: 30px;color:#262626;font-weight: 600;}h2{border-bottom: 1px solid #d8dee4; padding-bottom: 0.3em}.article_content ul{padding-left:22px;}截至2026年3月4日收盘，睿智医药报收于9.84元，下跌1.2%，换手率1.54%，成交量7.32万手，成交额7234.42万元。来自交易信息汇总：3月4日主力资金净流出479.27万元，游资资金净流入596.9万元。股东户数变动近日睿智医药披露，截至2026年2月27日公司股东户数为3.64万户，较2月13日增加2.0户，增幅为0.01%。户均持股数量由上期的1.37万股减少至1.37万股，户均持股市值为14.8万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260305/32045362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0216","300149","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616584585","title":"睿智医药：截至2026年2月27日，公司股东人数为36,371人","url":"https://stock-news.laohu8.com/highlight/detail?id=2616584585","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616584585?lang=zh_cn&edition=full","pubTime":"2026-03-04 15:15","pubTimestamp":1772608525,"startTime":"0","endTime":"0","summary":"证券之星消息，睿智医药(300149)03月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2月底股东人数有多少睿智医药回复：您好，感谢您对公司的关注。截至2026年2月27日，公司股东人数为36,371人。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400020886.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300149","BK0216"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778964312766,"stockEarnings":[{"period":"1week","weight":-0.0607},{"period":"1month","weight":-0.1855},{"period":"3month","weight":-0.141},{"period":"6month","weight":-0.1911},{"period":"1year","weight":0.5201},{"period":"ytd","weight":-0.0126}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.0131},{"period":"6month","weight":0.0363},{"period":"1year","weight":0.2232},{"period":"ytd","weight":0.042}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"睿智医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"45729人(较上一季度增加23.57%)","perCapita":"10377股","listingDate":"2010-12-22","address":"广东省江门市江海区胜利南路164号","registeredCapital":"49796万元","survey":" 睿智医药科技股份有限公司的主营业务是提供涵盖化学药研发以及生物药从早期发现到开发与规模化生产阶段的一体化服务。公司的主要产品是化学业务、药效药动业务、大分子业务。","listedPrice":28},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"睿智医药(300149)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供睿智医药(300149)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"睿智医药,300149,睿智医药股票,睿智医药股票老虎,睿智医药股票老虎国际,睿智医药行情,睿智医药股票行情,睿智医药股价,睿智医药股市,睿智医药股票价格,睿智医药股票交易,睿智医药股票购买,睿智医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"睿智医药(300149)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供睿智医药(300149)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}